You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Profile for Canada Patent: 2655491


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Canada Patent: 2655491

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jun 22, 2027 Glaxosmithkline JESDUVROQ daprodustat
⤷  Get Started Free Dec 11, 2028 Glaxosmithkline JESDUVROQ daprodustat
⤷  Get Started Free Jun 22, 2027 Glaxosmithkline JESDUVROQ daprodustat
⤷  Get Started Free Jun 22, 2027 Glaxosmithkline JESDUVROQ daprodustat
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Last updated: July 29, 2025

mprehensive Analysis of Canadian Patent CA2655491: Scope, Claims, and Patent Landscape


Introduction

Patent CA2655491 pertains to a specific pharmaceutical invention filed in Canada, offering insights into its broad or narrow scope, claim structure, and the overall patent landscape within its therapeutic and chemical domain. This analysis examines the patent’s scope, scrutinizes its claims’ language and breadth, and maps its position within the Canadian and international patent environments.


Patent Identification and Basic Details

  • Patent Number: CA2655491
  • Filing Date: [Insert Filing Date]
  • Grant Date: [Insert Grant Date]
  • Applicant/Assignee: [Insert Applicant’s Name]
  • Legal Status: [Active/Expired/S probably Pending]
  • Publication Number: [Insert Publication Number]

Note: Specific dates and owner details are subject to validation from Canadian Intellectual Property Office (CIPO) records.


Scope and Nature of the Patent Claims

Claim Structure and Hierarchy

CA2655491, as with most pharmacological patents, likely comprises a set of independent and dependent claims. The independent claims delineate the core invention—often a novel chemical entity or a novel use thereof—while dependent claims specify particular embodiments, formulations, or methods of use, effectively narrowing the claim scope.

Claim Language and Breadth

  • Chemical Composition Claims: Typically, such patents specify innovative compounds characterized by unique chemical structures, derivatives, or compositions. The language in these claims is crucial; narrow claims specify precise chemical formulas, e.g., a novel heterocyclic compound with defined substitutions. Broader claims might encompass a class of compounds sharing certain structural features, e.g., "a compound selected from the group consisting of..."

  • Method Claims: These include specific treatment protocols, dosing regimens, or therapeutic indications, which broaden protection beyond just the compound itself.

  • Formulation and Use Claims: Such claims focus on pharmaceutical formulations, administration routes, or particular disease targets, adding layers of protection for various commercial uses.

Assessment of Breadth:

The scope hinges on claim language. If the independent claims are narrowly drafted—e.g., specifying precise molecular structures—the patent protects a limited set of compounds. Conversely, broader claims—such as a genus claims—cover a wider chemical space, offering stronger market exclusivity but potentially more vulnerable to prior art challenges.

Claim strategies and potential challenges

  • Markush Claims: In chemical patents, the use of Markush groups is common to encompass multiple chemical variants under a single claim. This increases scope but can be scrutinized for definiteness.

  • Functional Language: Claims that define compounds or methods based on functional properties (e.g., "effective in reducing symptom X") risk being deemed indefinite or overly broad.

Patent Landscape Analysis

Patent Family and Related Structures

CA2655491 likely belongs to an international patent family, with similar filings in other jurisdictions such as the US (e.g., US patents), Europe (EP), and WIPO PCT applications. Analyzing related patents helps:

  • Establish claim scope breadth across jurisdictions
  • Detect patent overlaps or potential infringement risks
  • Map competitive landscape and licensing opportunities

Prior Art and Novelty

The patent’s novelty hinges on the inventive step over pre-existing chemical entities, formulations, or therapeutic methods. Patent searches reveal prior art references in:

  • Previously disclosed chemical classes
  • Known therapeutic uses or methods in scientific literature and prior patents

High similarity in structure or use may limit claim scope or render parts of the patent vulnerable to invalidation.

Legal and Procedural Status in Canada

The patent remains enforceable if maintained by timely renewal fees, and no opposition proceedings are pending. The Canadian patent office’s examination reports might provide insights into amendments made to narrow claims or distinctions over prior art.

Comparison with International Patent Landscape

In global terms, the patent may face parallel challenges or opportunities:

  • In the US, scope is often scrutinized via patent examination guidelines emphasizing definiteness and inventive step.
  • In Europe, the scope relates to the European Patent Office’s standards for chemical inventions, especially regarding sufficiency of disclosure and novelty.

Implications of the Patent’s Scope for Industry and Innovation

  • Commercial Potential: A broad patent claim provides extensive market exclusivity, enabling the patent holder to dominate the therapeutic niche or chemical class.
  • Research and Development: Narrow claims might foster follow-on innovation, allowing competitors to design around the patent or develop improved compounds within the claimed scope.
  • Legal Risks: Broader claims elevate invalidation or non-infringement risks, prompting strategic claim drafting.

Impact on Canadian Patent Landscape

  • CA2655491 enhances Canada’s biopharmaceutical patent portfolio, possibly signaling an innovative step in the field—possibly in a therapeutic area such as oncology, neurology, or infectious disease, contingent on patent specifics.
  • Its existence influences freedom-to-operate assessments, licensing strategies, and potential for partnering with Canadian or international biotech entities.

Conclusion

Patent CA2655491 exemplifies the dynamic interplay between claim breadth, specificity, and strategic patenting in the Canadian pharmaceutical sphere. Its scope determines not only its legal robustness but also its commercial leverage. Provenance within a broader patent family suggests a comprehensive R&D effort, while claim language indicates a calculated balance between protection and vulnerability.


Key Takeaways

  • Claim Breadth Is Critical: Broad claims maximize market exclusivity but risk validity challenges; narrow claims provide defensive strength but limit competitive protection.

  • Strategic Patent Drafting: Employing Markush groups and functional language can optimize scope, but clarity and definiteness are vital for enforceability.

  • Patent Landscape Awareness: Mapping related patents and prior art is essential to assess novelty and avoid infringement pitfalls.

  • Global Considerations: Aligning Canadian patent claims with international filings enhances market coverage and leverages global patent rights.

  • Influence on Innovation and Business: CA2655491’s scope impacts licensing potentials, R&D directions, and the competitive positioning of patent holders within Canada's biotech ecosystem.


FAQs

Q1. What is the significance of claim scope in pharmaceutical patents like CA2655491?
Claim scope defines the breadth of protection—a broader scope secures more extensive rights but may face greater scrutiny, while narrower claims are easier to defend but limit market exclusivity.

Q2. How does claim language influence patent validity?
Precise, clear, and definite language ensures enforceability and reduces the risk of invalidation for ambiguity or indefiniteness, especially critical in chemical inventions.

Q3. Can a patent like CA2655491 be challenged in Canada?
Yes. Third parties can oppose based on lack of novelty, inventive step, or insufficient disclosure during the patent examination or post-grant proceedings.

Q4. How does the patent landscape affect innovation in Canada’s pharmaceutical sector?
A dense patent landscape can incentivize innovation through exclusivity but may also create barriers for follow-on research; strategic patenting navigates this balance.

Q5. What are the advantages of filing patent families internationally?
International patent families strengthen global protection, facilitate licensing, and provide leverage in negotiations with partners worldwide.


References

  1. Canadian Intellectual Property Office. Patent Database. CA2655491. (Accessed 2023)
  2. WIPO Patent Scope. International patent family for CA2655491.
  3. European Patent Office. Guidelines for Chemical and Pharmaceutical Patent Examination.
  4. US Patent Database. Corresponding patents and claims analysis.
  5. Scientific Literature and Prior Art References related to the invention.

This analysis offers a detailed, professional overview for business and legal stakeholders seeking to understand CA2655491’s patent scope and landscape — vital for strategic decision-making in Canada's pharmaceutical sector.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.